Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Gebauer

Showing results (201-210 of 241) with videos related to

Pageof 25
Sort By:
European Radiology|October 16, 2024
Trans-arterial embolization for treatment of acute lower gastrointestinal bleeding-a multicenter analysisClarissa Hosse, Maximilian Moos, Lena S Becker, et al.
Cancers|April 26, 2025
Comparing the Prognostic Value of Quantitative Response Assessment Tools and LIRADS Treatment Response Algorithm in Patients with Hepatocellular Carcinoma Following Interstitial High-Dose-Rate Brachytherapy and Conventional Transarterial ChemoembolizationRobin Schmidt, Christopher Rueger, Han Xu, et al.
European Radiology|January 7, 2021
Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liverPaula M Oestmann, Clinton J Wang, Lynn J Savic, et al.
CVIR Endovascular|May 16, 2024
The status of academic interventional radiologists in Germany with focus on gender disparity: how can we do better?Sophia Freya Ulrike Blum, Cornelia Lieselotte Angelika Dewald, Lena Becker, et al.
Theranostics|May 7, 2026
Local and systemic cytokine signatures for outcome prediction after transarterial chemoembolization in hepatocellular carcinomaEmine Y Yilmaz, Robin Schmidt, Luisa Heidemann, et al.
British Journal of Cancer|October 23, 2021
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinomaOsman Öcal, Michael Ingrisch, Muzaffer Reha Ümütlü, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 5, 2022
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenibOsman Öcal, Regina Schinner, Kerstin Schütte, et al.
Frontiers in Oncology|March 14, 2022
Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring SystemsLukas Müller, Felix Hahn, Timo Alexander Auer, et al.
Frontiers in Radiology|February 18, 2026
Effects of contrast medium injection pressure on angiographic image qualitySara A Abosabie, Tabea Kao, Timo Alexander Auer, et al.
United European Gastroenterology Journal|December 17, 2021
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Pageof 25

Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
European Radiology|October 16, 2024
Trans-arterial embolization for treatment of acute lower gastrointestinal bleeding-a multicenter analysisClarissa Hosse, Maximilian Moos, Lena S Becker, et al.
Cancers|April 26, 2025
Comparing the Prognostic Value of Quantitative Response Assessment Tools and LIRADS Treatment Response Algorithm in Patients with Hepatocellular Carcinoma Following Interstitial High-Dose-Rate Brachytherapy and Conventional Transarterial ChemoembolizationRobin Schmidt, Christopher Rueger, Han Xu, et al.
European Radiology|January 7, 2021
Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liverPaula M Oestmann, Clinton J Wang, Lynn J Savic, et al.
CVIR Endovascular|May 16, 2024
The status of academic interventional radiologists in Germany with focus on gender disparity: how can we do better?Sophia Freya Ulrike Blum, Cornelia Lieselotte Angelika Dewald, Lena Becker, et al.
Theranostics|May 7, 2026
Local and systemic cytokine signatures for outcome prediction after transarterial chemoembolization in hepatocellular carcinomaEmine Y Yilmaz, Robin Schmidt, Luisa Heidemann, et al.
British Journal of Cancer|October 23, 2021
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinomaOsman Öcal, Michael Ingrisch, Muzaffer Reha Ümütlü, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 5, 2022
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenibOsman Öcal, Regina Schinner, Kerstin Schütte, et al.
Frontiers in Oncology|March 14, 2022
Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring SystemsLukas Müller, Felix Hahn, Timo Alexander Auer, et al.
Frontiers in Radiology|February 18, 2026
Effects of contrast medium injection pressure on angiographic image qualitySara A Abosabie, Tabea Kao, Timo Alexander Auer, et al.
United European Gastroenterology Journal|December 17, 2021
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationLukas Müller, Felix Hahn, Aline Mähringer-Kunz, et al.
Pageof 25